Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Marisa Banasik"'
Autor:
Yali Qin, Saikat Banerjee, Aditi Agrawal, Heliang Shi, Marisa Banasik, Feng Lin, Kari Rohl, Celia LaBranche, David C Montefiori, Michael W Cho
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0128823 (2015)
We recently reported the induction of potent, cross-clade neutralizing antibodies (nAbs) against Human Immunodeficiency Virus type-1 (HIV-1) in rabbits using gp120 based on an M-group consensus sequence. To better characterize these antibodies, 93 hy
Externí odkaz:
https://doaj.org/article/3b15470e6bcf4ae28cd5caeafc3ab023
Autor:
Yali Qin, Hojin Moon, Andrew Harley, Heliang Shi, Michael W. Cho, William D. Lees, Adrian J. Shepherd, Marisa Banasik, Saikat Banerjee
Publikováno v:
Virology. 505:113-126
The membrane proximal external region (MPER) of HIV-1 gp41 is targeted by broadly neutralizing antibodies (bnAbs) 4E10 and 10E8. In this proof-of-concept study, we evaluated a novel multi-immunogen vaccine strategy referred to as Incremental, Phased
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9afa206b7458a1f4dd41805bdd3e302
https://doi.org/10.1016/j.virol.2017.02.015
https://doi.org/10.1016/j.virol.2017.02.015
Autor:
Adrian J. Shepherd, Michael W. Cho, Ruimin Pan, Yali Qin, William D. Lees, Marisa Banasik, Xiang-Peng Kong
The third variable (V3) loop of HIV-1 gp120 is an immunodominant region targeted by neutralizing antibodies (nAbs). Despite limited breadth, better characterization of the structural details of the interactions between these nAbs and their target epi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cee584473bfee9171415689a9de3dfdb
https://eprints.bbk.ac.uk/id/eprint/21137/341/JVI.01894-17.pdf
https://eprints.bbk.ac.uk/id/eprint/21137/341/JVI.01894-17.pdf
Autor:
David C. Montefiori, Chong Wang, Adam Penn-Nicholson, Celia C. LaBranche, Habtom H. Habte, Yali Qin, SoonJeung Kim, Michael W. Cho, Marisa Banasik
Publikováno v:
Virology. :363-376
One strategy being evaluated for HIV-1 vaccine development is focusing immune responses towards neutralizing epitopes on the gp120 outer domain (OD) by removing the immunodominant, but non-neutralizing, inner domain. Previous OD constructs have not e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7409f48763a6ed6d318a2ad6d35e83c
https://doi.org/10.1016/j.virol.2014.06.006
https://doi.org/10.1016/j.virol.2014.06.006
Publikováno v:
Retrovirology
Background We recently reported induction of broadly neutralizing antibodies (bnAbs) against multiple HIV-1 (human immunodeficiency virus type 1) isolates in rabbits, albeit weak against tier 2 viruses, using a monomeric gp120 derived from an M group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1501653339afc57ac6fe3ef3fcaee2c8
https://doi.org/10.1186/s12977-014-0125-5
https://doi.org/10.1186/s12977-014-0125-5
Publikováno v:
Molecular Therapy. 13
We are investigating the nonprimate FIV lentiviral vector for gene transfer applications. Although this vector can integrate in transduced cells, little is known about the fate of FIV vector in host cells after infection. Transgenic DNA can persist a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5404204c40f549d140ac38247b3785d
Publikováno v:
Molecular Therapy. 11:S41
Lentiviral vectors mediate long term transgene expression through integration into host genomic DNA. However, integration comes with potential risks of insertional mutagenesis. In cases where transient gene expression is desired, an integrase (IN) de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c133f6c04064c8b4a27a3c9ae4478abf
https://doi.org/10.1016/j.ymthe.2005.06.106
https://doi.org/10.1016/j.ymthe.2005.06.106